{"id":"https://openalex.org/W4393071972","doi":"https://doi.org/10.1158/1538-7445.am2024-4605","title":"Abstract 4605: AZD4573 in combination with CHOP increases combination benefit in preclinical peripheral T-cell lymphoma models","display_name":"Abstract 4605: AZD4573 in combination with CHOP increases combination benefit in preclinical peripheral T-cell lymphoma models","alternate_titles":[],"publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393071972","doi":"https://doi.org/10.1158/1538-7445.am2024-4605"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4605","doi":"https://doi.org/10.1158/1538-7445.am2024-4605","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4605","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4393071972"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055716145","display_name":"Danielle S. Potter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Danielle Sinead Potter","raw_affiliation_strings":["1AstraZeneca Oncology, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Oncology, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111084174","display_name":"India Ott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"India Ott","raw_affiliation_strings":["1AstraZeneca Oncology, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Oncology, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001466285","display_name":"Jamal Carlos Saeh","orcid":"https://orcid.org/0000-0001-6396-6257","observed_orcids":["https://orcid.org/0000-0001-6396-6257"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jamal Saeh","raw_affiliation_strings":["1AstraZeneca Oncology, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Oncology, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074028658","display_name":"Richard F. Olsson","orcid":"https://orcid.org/0000-0001-5970-2128","observed_orcids":["https://orcid.org/0000-0001-5970-2128"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Olsson","raw_affiliation_strings":["2AstraZeneca Oncology, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca Oncology, Gothenburg, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091683932","display_name":"Stephen E. Fawell","orcid":"https://orcid.org/0000-0002-1962-891X","observed_orcids":["https://orcid.org/0000-0002-1962-891X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen Fawell","raw_affiliation_strings":["1AstraZeneca Oncology, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Oncology, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090795154","display_name":"Lisa Drew","orcid":"https://orcid.org/0000-0002-5912-8338","observed_orcids":["https://orcid.org/0000-0002-5912-8338"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa Drew","raw_affiliation_strings":["1AstraZeneca Oncology, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Oncology, Waltham, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110203961","display_name":"Justine E. Roderick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Justine Roderick","raw_affiliation_strings":["1AstraZeneca Oncology, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Oncology, Waltham, MA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4605","last_page":"4605"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azd4573","display_name":"AZD4573","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cdk9-inhibition","display_name":"CDK9 inhibition","score":0.8849999904632568},{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.9679999947547913},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8690000176429749},{"id":"https://openalex.org/keywords/bfl-1","display_name":"Bfl-1","score":0.9639999866485596},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9139999747276306},{"id":"https://openalex.org/keywords/rna-polymerase-ii-phosphorylation","display_name":"RNA polymerase II phosphorylation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7200000286102295},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.7250000238418579},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.6902123093605042},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6072713136672974},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5762422680854797},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.5630016326904297},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.45935654640197754},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4436924457550049},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4379664659500122},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3480907082557678},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22011151909828186},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.16504263877868652},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4605","doi":"https://doi.org/10.1158/1538-7445.am2024-4605","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4605","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389220175","https://openalex.org/W4386047259","https://openalex.org/W4244369116","https://openalex.org/W3214410062","https://openalex.org/W4389220440","https://openalex.org/W4393087791","https://openalex.org/W4393097122","https://openalex.org/W4389229781","https://openalex.org/W4411325883","https://openalex.org/W7128707676"],"abstract_inverted_index":{"Peripheral":[0],"T-cell":[1,467],"Lymphoma":[2],"(pTCL)":[3],"makes":[4],"up":[5],"about":[6],"10%":[7],"of":[8,28,43,49,56,97,122,172,185,196,201,214,234,262,283,473],"non-Hodgkin's":[9],"lymphoma":[10,468],"in":[11,86,103,113,129,147,153,177,180,207,255,315,336,366,371,381,394,397,400,426,437,457,464],"the":[12,34,41,47,94,98,110,134,170,173,199,215,271,359,369,474],"United":[13],"States.":[14],"Patients":[15],"with":[16,71,131,151,220,326,355,376,385,420,428,459],"relapsed/refractory":[17],"pTCL":[18,31,104,114,157,186,204,237,289,317,333,372],"have":[19,167],"limited":[20],"treatment":[21,48,192,243,253,393,419],"options":[22],"and":[23,65,80,227,247,249,258,264,285,296,342,388],"poor":[24],"prognosis.":[25],"Current":[26],"standard":[27],"care":[29],"for":[30,46,298,358,477],"revolves":[32],"around":[33],"chemotherapy":[35],"regimens":[36],"CHOP/E.":[37],"Here":[38],"we":[39,142,166,274,330],"examine":[40],"efficacy":[42,310,370],"CDK9":[44,51,67],"inhibition":[45,70],"pTCL.":[50,438],"regulates":[52],"transcription":[53],"through":[54,313,413],"phosphorylation":[55],"RNA":[57],"polymerase":[58],"II.":[59],"AZD4573":[60,72,191,242,252,306,325,356,363,421,456],"is":[61,126,311],"a":[62,183,194,208,230,337,398,423],"highly":[63,127],"potent":[64],"selective":[66],"inhibitor;":[68],"acute":[69],"downregulates":[73],"short-lived":[74],"proteins":[75],"such":[76],"as":[77,422],"MCL-1,":[78,405],"BFL-1,":[79],"c-MYC,":[81],"which":[82],"are":[83],"often":[84],"overexpressed":[85],"hematologic":[87],"tumors.":[88],"It":[89],"has":[90],"been":[91],"shown":[92],"that":[93,239,309,407,418],"expression":[95,111],"pattern":[96],"anti-apoptotic":[99,174],"BCL-2":[100,123],"family":[101,124],"members":[102,125],"cell":[105,178,205,216,290,318,334,374,383],"line":[106,384],"models":[107,159,469],"closely":[108],"resembled":[109],"patterns":[112],"patient":[115],"samples":[116],"(Koch":[117,160],"et":[118,161,188],"al.":[119,162],"2019).":[120,163],"Expression":[121],"heterogeneous":[128],"pTCL,":[130],"MCL-1":[132,139,154,297,303,314,377],"being":[133],"most":[135],"universally":[136],"expressed.":[137],"Using":[138],"inhibitor":[140],"AZD5991,":[141],"showed":[143,193],"statistically":[144],"significant":[145],"benefit":[146,409,463],"survival":[148,179],"when":[149],"combined":[150],"CHOP":[152,327,354,365,392,429,460],"dependent":[155,293],"preclinical":[156,465],"PDX":[158],"In":[164],"addition,":[165],"previously":[168],"reported":[169],"importance":[171],"protein":[175,260],"BFL-1":[176],"NHL,":[181],"including":[182],"subset":[184],"(Boiko":[187],"al":[189],"2021).":[190],"range":[195],"activity":[197],"across":[198],"panel":[200],"18":[202],"human":[203],"lines,":[206],"6-hour":[209],"caspase-3/7":[210],"activation":[211,233],"assay.":[212],"14":[213],"lines":[217,291,319,335,375],"were":[218,292],"sensitive,":[219],"EC50":[221],"values":[222],"less":[223],"than":[224],"100":[225],"nM,":[226],"13":[228],"reached":[229],"max":[231],"caspase":[232],"over":[235],"40%.":[236],"subtypes":[238],"responded":[240],"to":[241,353,364,390],"included":[244],"ALCL,":[245],"NK-TCL,":[246],"PTCL-NOS":[248],"CTCL.":[250],"Acute":[251],"resulted":[254,396],"decreased":[256],"pSer2-RNAP2":[257],"reduced":[259],"levels":[261,402],"c-MYC":[263,295,401],"MCL-1.":[265],"To":[266,321],"determine":[267,322],"what":[268],"was":[269],"driving":[270],"apoptotic":[272],"phenotype,":[273],"used":[275],"ribonucleoprotein":[276],"(RNP)":[277],"mediated":[278,312],"CRISPR":[279],"knock":[280],"out":[281],"(KO)":[282],"MYC":[284],"MCL1":[286],"genes.":[287],"While":[288],"on":[294],"viability":[299,344],"after":[300,345,350],"KO,":[301],"only":[302],"KO":[304],"impaired":[305],"treatment,":[307],"suggesting":[308,406],"ALCL":[316,373],"assessed.":[320],"if":[323],"combining":[324],"improved":[328],"efficacy,":[329],"tested":[331],"5":[332],"6x6":[338],"combination":[339,408,427,458,462],"dosing":[340],"matrix":[341],"measured":[343],"24-72":[346],"hours":[347],"using":[348],"RealTime-Glo":[349],"24hr":[351],"exposure":[352],"added":[357],"last":[360],"6hrs.":[361],"Adding":[362],"vitro":[367,395],"increased":[368],"dependency,":[378],"but":[379,403],"not":[380,404],"CTCL":[382],"BCL-xL":[386],"dependency":[387],"resistance":[389],"AZD4573.":[391],"decrease":[399],"may":[410],"be":[411,432],"driven":[412],"c-MYC.":[414],"This":[415],"data":[416],"suggests":[417],"monotherapy":[424],"or":[425],"regimen":[430],"would":[431],"an":[433],"effective":[434],"therapeutic":[435],"strategy":[436],"Citation":[439],"Format:":[440],"Danielle":[441],"Sinead":[442],"Potter,":[443],"India":[444],"Ott,":[445],"Jamal":[446],"Saeh,":[447],"Richard":[448],"Olsson,":[449],"Stephen":[450],"Fawell,":[451],"Lisa":[452],"Drew,":[453],"Justine":[454],"Roderick.":[455],"increases":[461],"peripheral":[466],"[abstract].":[470],"In:":[471],"Proceedings":[472],"American":[475],"Association":[476],"Cancer":[478,496],"Research":[479],"Annual":[480],"Meeting":[481],"2024;":[482],"Part":[483],"1":[484],"(Regular":[485],"Abstracts);":[486],"2024":[487],"Apr":[488],"5-10;":[489],"San":[490],"Diego,":[491],"CA.":[492],"Philadelphia":[493],"(PA):":[494],"AACR;":[495],"Res":[497],"2024;84(6_Suppl):Abstract":[498],"nr":[499],"4605.":[500]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4393071972","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2024-03-23T00:00:00"}
